Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells

Oncogene

Volumn 23, Issue 1, 2004, Pages 157-167

  Fernandis, Aaron Zefrin ^a   Prasad, Anil ^a   Band, Hamid ^b   Klösel, Roland ^c   Ganju, Ramesh Kumar ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Biontex Laboratories GmbH   (Germany)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Chemoinvasion; Chemotaxis; CXCR4; Focal adhesion; Metastasis; Signaling

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; METALLOPROTEINASE; PAXILLIN; PHOSPHOTYROSINE;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; EVALUATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CHEMOKINES, CXC; CHEMOTAXIS; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION KINASE 2; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CXCR4; TYROSINE;

EID: 0942301172     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206910     Document Type: Article

References (64)

1. Andoniou CE, Thien CB and Langdon WY. (1994). EMBO J., 13, 4515-4523.
2. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY and Slamon DJ. (2003). Cancer Res., 63, 196-206.
3. Avraham H, Park SY, Schinkmann K and Avraham S. (2000). Cell Signal, 12, 123-133.
4. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J and Springer TA. (1996). Nature, 382, 829-833.
5. Camacho SA, Heath WR, Carbone FR, Sarvetnick N, LeBon A, Karlsson L, Peterson PA and Webb SR. (2001). Nat. Immunol., 2, 523-529.
6. Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD and Karlan BY. (2001). Gynecol. Oncol., 80, 56-61.
7. Cherla RP and Ganju RK. (2001). J. Immunol., 166, 3067-3074.
8. Chernock RD, Cherla RP and Ganju RK. (2001). Blood, 97, 608-615.
9. Duong LT and Rodan GA. (2000). Cell Motil. Cytoskeleton, 47, 174-188.
10. Fernandis AZ, Cherla RP and Ganju RK. (2003). J. Biol. Chem., 278, 9536-9543.
11. Feshchenko EA, Shore SK and Tsygankov AY. (1999). Oncogene, 18, 3703-3715.
12. Fournier TM, Lamorte L, Maroun CR, Lupher M, Band H, Langdon W and Park M. (2000). Mol. Biol. Cell, 11, 3397-3410.
13. Fuortes M, Melchior M, Han H, Lyon GJ and Nathan C. (1999). J. Clin. Invest., 104, 327-335.
14. Ganju RK, Brubaker SA, Chernock RD, Avraham S and Groopman JE. (2000). J. Biol. Chem., 275, 17263-17268.
15. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W and Groopman JE. (1998a). J. Biol. Chem., 273, 23169-23175.
16. Ganju RK, Dutt P, Wu L, Newman W, Avraham H, Avraham S and Groopman JE. (1998b). Blood, 91, 791-797.
17. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP and Ben-Baruch A. (2001). J. Immunol., 167, 4747-4757.
18. Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ and Gutierrez-Ramos JC. (2000). J. Immunol., 165, 499-508.
19. Greenlee RT, Murray T, Bolden S and Wingo PA. (2000). CA Cancer J. Clin., 50, 7-33.
20. Hamasaki K, Mimura T, Morino N, Furuya H, Nakamoto T, Aizawa S, Morimoto C, Yazaki Y, Hirai H and Nojima Y. (1996). Biochem. Biophys. Res. Commun., 222, 338-343.
21. Hatch WC, Ganju RK, Hiregowdara D, Avraham S and Groopman JE. (1998). Blood, 91, 3967-3973.
22. Hilakivi-Clarke L. (2000). Cancer Res., 60, 4993-5001.
23. Huminiecki L, Gorn M, Suchting S, Poulsom R and Bicknell R. (2002). Genomics, 79, 547-552.
24. Hyder SM, Chiappetta C and Stancel GM. (2001). Int. J. Cancer, 92, 469-473.
25. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA and Dinney CP. (2000a). Clin. Cancer Res., 6, 2104-2119.
26. Itoh Y and Nagase H. (2002). Essays Biochem., 38, 21-36.
27. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R and Dinney CP. (2000b). Cancer Res., 60, 2290-2299.
28. Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ and Cabuhat ML. (2000). Exp. Hematol., 28, 1274-1285.
29. Kim H and Muller WJ. (1999). Exp. Cell Res., 253, 78-87.
30. Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG, Janowska-Wieczorek A and Ratajczak MZ. (2002). Blood, 100, 2597-2606.
31. Lill NL, Douillard P, Awwad RA, Ota S, Lupher Jr ML, Miyake S, Meissner-Lula N, Hsu VW and Band H. (2000). J. Biol. Chem., 275, 367-377.
32. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M and Moser B. (1994). J. Biol. Chem., 269, 232-237.
33. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R and Bar-Eli M. (1997). Am. J. Pathol., 151, 1105-1113.
34. Lupher Jr ML, Rao N, Eck MJ and Band H. (1999). Immunol. Today, 20, 375-382.
35. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA and Martinez AC. (1999). Mol. Cell Biol., 19, 3125-3135.
36. Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H and Mori M. (2002). Cancer Res., 62, 2937-2941.
37. McEarchern JA, Kobie JJ, Mack V, Wu RS, Meade-Tollin L, Arteaga CL, Dumont N, Besselsen D, Seftor E, Hendrix MJ, Katsanis E and Akporiaye ET. (2001). Int. J. Cancer, 91, 76-82.
38. McPherson K, Steel CM and Dixon JM. (2000). BMJ, 321, 624-628.
39. Miyake S, Mullane-Robinson KP, Lill NL, Douillard P and Band H. (1999). J. Biol. Chem., 274, 16619-16628.
40. Mohle R, Schittenhelm M, Failenschmid C, Bautz F, Kratz-Albers K, Serve H, Brugger W and Kanz L. (2000). Br. J. Haematol., 110, 563-572.
41. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E and Zlotnik A. (2001). Nature, 410, 50-56.
42. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO and Hwang ST. (2002). Cancer Res., 62, 7328-7334.
43. Nabeshima K, Inoue T, Shimao Y and Sameshima T. (2002). Pathol. Int., 52, 255-264.
44. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M and Moser B. (1996). Nature, 382, 833-835.
45. Payne AS and Cornelius LA. (2002). J. Invest. Dermatol., 118, 915-922.
46. Premack BA and Schall TJ. (1996). Nat. Med., 2, 1174-1178.
47. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sanchez-Mateos P and Teixido J. (2001). J. Biol. Chem., 276, 45098-45105.
48. Rollins BJ. (1997). Blood, 90, 909-928.
49. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC and Baron R. (2001). J. Cell. Biol., 152, 181-195.
50. Saphner T, Tormey DC and Gray R. (1996). J. Clin. Oncol., 14, 2738-2746.
51. Saxton TM and Pawson T. (1999). Proc. Natl. Acad. Sci. USA, 96, 3790-3795.
52. Scaife RM and Langdon WY. (2000). J. Cell Sci., 113, 215-226.
53. Schlaepfer DD, Hauck CR and Sieg DJ. (1999). Prog. Biophys. Mol. Biol., 71, 435-478.
54. Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR. (2001). Cancer Res., 61, 4961-4965.
55. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G and Balkwill FR. (2002). Cancer Res., 62, 5930-5938.
56. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS and McCauley LK. (2002). Cancer Res., 62, 1832-1837.
57. Thompson EW and Price JT. (2002). Expert Opin. Ther. Targets, 6, 217-233.
58. Uemura N and Griffin JD. (1999). J. Biol. Chem., 274, 37525-37532.
59. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T and Rijksen G. (1998). FEBS Lett., 425, 145-150.
60. Wade R, Bohl J and Vande Pol S. (2002). Oncogene, 21, 96-107.
61. Wang JF, Park IW and Groopman JE. (2000). Blood, 95, 2505-2513.
62. Yoshie O. (2000). Int. J. Hematol., 72, 399-407.
63. Youngs SJ, Ali SA, Taub DD and Rees RC. (1997). Int. J. Cancer, 71, 257-266.
64. Zhang XF, Wang JF, Matczak E, Proper JA and Groopman JE. (2001). Blood, 97, 3342-3348.